DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
Frequently asked questions
What sector does Dashenlin Pharm Grp Co Ltd (603233) operate in?
Dashenlin Pharm Grp Co Ltd belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is Dashenlin Pharm Grp Co Ltd (603233) current stock price?
As of the latest data, Dashenlin Pharm Grp Co Ltd stock price is CN¥17.55, with a previous close of CN¥17.97. Dashenlin Pharm Grp Co Ltd lost -CN¥0.42 in the last trading session, representing a -2.34% loss.
What is Dashenlin Pharm Grp Co Ltd (603233) current market capitalization?
Dashenlin Pharm Grp Co Ltd market cap is approximately 19.99 billion.
What is Dashenlin Pharm Grp Co Ltd (603233) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.19, and the forward EPS is CN¥1.57.
What is Dashenlin Pharm Grp Co Ltd (603233) Price-to-Earnings (P/E) ratio?
Dashenlin Pharm Grp Co Ltd current P/E ratio is 14.75, with a forward P/E of 11.18.
Does Dashenlin Pharm Grp Co Ltd (603233) pay dividends?
No. Dashenlin Pharm Grp Co Ltd does not pay a dividend.
How did Dashenlin Pharm Grp Co Ltd (603233) perform in its most recent earnings report?
In the last report (June 30, 2026), Dashenlin Pharm Grp Co Ltd posted an EPS surprise of -2.17% and a revenue surprise of -2.93%.
What is Dashenlin Pharm Grp Co Ltd (603233) beta (volatility) score?
Dashenlin Pharm Grp Co Ltd has a beta of 0.412, indicating lower volatility than the overall market.
